Daily Oncology News

Cetuximab may be beneficial beyond progression in certain patients with mCRC

Cetuximab may be beneficial beyond progression in certain patients with mCRC

Continuing second-line cetuximab beyond progression following first-line chemotherapy and an anti-EGFR monoclonal antibody is beneficial for quadruple wild-type metastatic colorectal cancer.

Study confirms benefit of regorafenib in previously treated metastatic colorectal cancer

Study confirms benefit of regorafenib in previously treated metastatic colorectal cancer

Researchers have confirmed that regorafenib is beneficial for the treatment of patients with previously treated metastatic colorectal cancer.

Perception of risk from tobacco use is lower among cancer survivors who smoke

Perception of risk from tobacco use is lower among cancer survivors who smoke

A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit.

Early relapse of follicular lymphoma may increase risk of death

Early relapse of follicular lymphoma may increase risk of death

Early relapse of follicular lymphoma could be carefully considered when making decisions about treatment for these patients.

Study identifies perception gap in incidence, impact of CINV/RINV

Study identifies perception gap in incidence, impact of CINV/RINV

There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of CINV/RINV.

Survival in adult patients with low-grade brain tumors has improved

Survival in adult patients with low-grade brain tumors has improved

Outcomes for patients with low-grade gliomas have improved significantly in recent years, according to an analysis of clinical data collected from a US cancer registry over the past decade.

Low dose radiation from medical imaging may not raise cancer risk

Low dose radiation from medical imaging may not raise cancer risk

Low-dose radiation from X-rays, CT scans, and other medical imaging devices may not cause cancer, despite widespread belief to the contrary.

Age-adjusted comorbidity score stratifies mortality in prostate cancer

Age-adjusted comorbidity score stratifies mortality in prostate cancer

Age-adjusted prostate cancer-specific comorbidity index is strongly predictive of other-cause mortality, according to recent study data.

Addition of aprepitant may improve vomiting control in patients receiving oxaliplatin

Addition of aprepitant may improve vomiting control in patients receiving oxaliplatin

A three-drug combination antiemetic therapy including aprepitant or fosaprepitant improved the prevention rate of nausea and vomiting.

Thin colorectal cancer patients have shorter survival than obese patients

Thin colorectal cancer patients have shorter survival than obese patients

Thin patients with colorectal cancer have shorter survival than obese patients.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs